Related Experiment Videos
Myocardial revascularization in 1997: angioplasty versus bypass surgery
1University of Southern California School of Medicine, Los Angeles, USA.
Insights
For severe coronary artery disease, bypass surgery and angioplasty offer similar survival rates in most patients. However, bypass surgery is superior for diabetic patients, reducing mortality significantly.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiac Surgery
Background:
- Coronary artery disease (CAD) affects millions globally, necessitating effective revascularization strategies.
- Percutaneous coronary intervention (angioplasty) and coronary artery bypass grafting (CABG) are primary treatments for severe CAD.
- Comparative effectiveness of these revascularization methods is crucial for clinical decision-making.
Purpose of the Study:
- To compare the long-term outcomes of angioplasty versus bypass surgery in patients with multivessel coronary artery disease.
- To evaluate differences in mortality, reinfarction rates, need for repeat procedures, and cost-effectiveness.
- To specifically assess treatment efficacy in diabetic versus non-diabetic patient populations.
Main Methods:
- Analysis of six major randomized trials comparing bypass surgery and angioplasty.
- Five-year follow-up data on mortality, reinfarction, and repeat interventions.
- Economic evaluation of both procedures over the five-year period.
Main Results:
- No significant difference in five-year mortality or reinfarction rates between angioplasty and bypass surgery in the overall patient cohort.
- Significantly higher rates of repeat procedures required after angioplasty (30-40%) compared to bypass surgery (5-10%).
- Similar five-year costs for both procedures, despite initial lower costs for angioplasty.
- A twofold reduction in mortality rates observed with bypass surgery compared to angioplasty in diabetic patients.
Conclusions:
- Bypass surgery and angioplasty demonstrate comparable efficacy regarding mortality and reinfarction in non-diabetic patients with severe coronary artery disease.
- Bypass surgery is the preferred revascularization strategy for diabetic patients with severe coronary artery disease due to superior survival outcomes.
- While angioplasty may require more repeat interventions, long-term costs are similar to bypass surgery, but survival benefits in diabetics favor bypass.
Abstract:
In patients with coronary artery disease and severe ischemia, angioplasty and coronary artery bypass surgery have been shown to reduce symptoms, improve functional capacity and, in some patients, prolong life. Six major randomized trials have recently been reported comparing bypass surgery with angioplasty in patients with multivessel coronary disease. Uniformly, these studies demonstrate an equal mortality and reinfarction rate over five years of follow-up. Patients with angioplasties needed a repeat procedure during follow-up far more frequently than patients with bypass needed an additional bypass procedure (30 to 40 percent versus 5 to 10 percent). Although angioplasty was initially less costly, over five years the costs for the two procedures were similar. Mortality rates decreased by twofold when patients with diabetes mellitus were treated with bypass surgery rather than angioplasty. These studies confirm that in nondiabetic patients, bypass surgery and angioplasty are equally effective in the treatment of severe coronary disease. In diabetic patients with severe disease, however, bypass surgery is favored.